CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21

Description

Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI AUTO03-A2

Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard, Second Edition, AUTO03A2

$90.00 $180.00

CLSI M11-S1

Performance Standards for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Informational Supplement, M11S1

$105.00 $210.32

CLSI POCT07-P

Quality Management: Approaches to Reducing Errors at the Point of Care; Proposed Guideline, POCT07P

$138.00 $276.82

CLSI EP25-A

Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline, EP25A

$90.00 $180.00